StockData
Ernexa Therapeutics Inc. logo

Ernexa Therapeutics Inc. (ERNA) stock

ERNANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ERNAW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$1.63−0.06 (-3.55%)

Close on Nov 17, 2026Market cap $2.66MP/E –Yield –

Ernexa Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Ernexa Therapeutics's price to sales ratio was 456.9× on Apr 30, 2025, against 176.1× a year earlier. Over the last 4 years it ranged from 28.7× to 456.9×, with a median of 74.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 2025456.9×+423.3
2019Oct 31, 201933.6×−24.4
2018Jan 31, 201858.1×+14.6
2017Dec 29, 201743.4×−132.7
2014Jan 31, 2014176.1×+0.0
2013Dec 31, 2013176.1×+120.7
2012Dec 31, 201255.4×−1.4
2011Dec 30, 201156.8×–

More Ernexa Therapeutics figures

See a number that looks wrong?